Article metrics
PDF
Other content recommended for you
- The ethics of placebo treatments in clinical practice: a reply to Glackin
- Placebo treatments, informed consent and ‘the grip of a false picture’
- Deception, intention and clinical practice
- Ethics of placebo use in clinical practice: why we need to look beyond deontology
- The moral case for the clinical placebo
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
- Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives
- Pretending to care
- Variability in the Response to Cyclooxygenase Inhibitors
- Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management